Clinical Trials Browser

Phase 1 × ProMune × Tumor-Agnostic × Clear all

NCT00199836 2022-10-10

A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.

Phase 1 Completed

14 enrolled 11 charts

Neoplasms